Carna Biosciences Inc
TSE:4572

Watchlist Manager
Carna Biosciences Inc Logo
Carna Biosciences Inc
TSE:4572
Watchlist
Price: 436 JPY Market Closed
Market Cap: ¥8.3B

Operating Margin

-376.5%
Current
Declining
by 180.1%
vs 3-y average of -196.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-376.5%
=
Operating Income
¥-2B
/
Revenue
¥544.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-376.5%
=
Operating Income
¥-2B
/
Revenue
¥544.4m

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Carna Biosciences Inc
TSE:4572
8.3B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.4B USD
Loading...
US
Danaher Corp
NYSE:DHR
166B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 99% of companies in Japan
Percentile
1st
Based on 6 730 companies
1st percentile
-376.5%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Carna Biosciences Inc
Glance View

Carna Biosciences, Inc. engages in the drug discovery business. The company is headquartered in Kobe, Hyogo-Ken and currently employs 64 full-time employees. The company went IPO on 2008-03-25. The firm operates in two business segments. The Drug Development Support segment is engaged in sales of protein kinase, development of assay, as well as provision of profiling and screening service. The Drug Development segment is engaged in the research and development of kinase inhibitors and other drugs.

Carna Biosciences Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-376.5%
=
Operating Income
¥-2B
/
Revenue
¥544.4m
What is Carna Biosciences Inc's current Operating Margin?

The current Operating Margin for Carna Biosciences Inc is -376.5%, which is below its 3-year median of -196.4%.

How has Operating Margin changed over time?

Over the last 3 years, Carna Biosciences Inc’s Operating Margin has decreased from -4.7% to -376.5%. During this period, it reached a low of -376.5% on Oct 30, 2025 and a high of -4.7% on Aug 30, 2022.

Back to Top